Richard Jude Samulski (R Jude Samulski)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Blood Brain Barrier

Top Venues

Human gene therapy

Expert opinion on biological therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Tierney B Daw, Hala G El-Nahal, Michele A Basso, Elizabeth J Jun, Alex R Bautista, Richard Jude Samulski, Marc A Sommer, Martin O Bohlen
Direct Comparison of Epifluorescence and Immunostaining for Assessing Viral Mediated Gene Expression in the Primate Brain. Human gene therapy 34 (5-6) (2023)
Tierney B Daw, Hala G El-Nahal, Michele A Basso, Elizabeth J Jun, Alex R Bautista, Richard Jude Samulski, Marc A Sommer, Martin O Bohlen
Direct Comparison of Epifluorescence and Immunostaining for Assessing Viral Mediated Gene Expression in the Primate Brain. Human gene therapy (2023)
Tierney B Daw, Hala G El-Nahal, Michele A Basso, Elizabeth J Jun, Alex R Bautista, Richard Jude Samulski, Marc A Sommer, Martin O Bohlen
Direct Comparison of Epifluorescence and Immunostaining for Assessing Viral Mediated Gene Expression in the Primate Brain. Human gene therapy 34 (5-6) (2023)
Tierney B Daw, Hala G El-Nahal, Michele A Basso, Elizabeth J Jun, Alex R Bautista, Richard Jude Samulski, Marc A Sommer, Martin O Bohlen
Direct Comparison of Epifluorescence and Immunostaining for Assessing Viral Mediated Gene Expression in the Primate Brain. Human gene therapy 34 (5-6) (2023)
Iker Arriaga, Aitor Navarro, Amaia Etxabe, César Trigueros, Richard Jude Samulski, Philippe Moullier, Achille François, Nicola G A Abrescia
Cellular and Structural Characterization of VP1 and VP2 Knockout Mutants of AAV3B Serotype and Implications for AAV Manufacturing. Human gene therapy 33 (21-22) (2022)
Takashi Kei Kishimoto, Richard Jude Samulski
Addressing high dose AAV toxicity - 'one and done' or 'slower and lower'? Expert opinion on biological therapy 22 (9) (2022)